HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The clinical utility of serum anti-Müllerian hormone in the follow-up of ovarian adult-type granulosa cell tumors--A comparative study with inhibin B.

Abstract
Ovarian adult-type granulosa cell tumors (AGCTs) require prolonged follow-up, but evidence regarding the optimal follow-up marker is lacking. The objective of our study was to validate the clinical usefulness of serum anti-Müllerian hormone (AMH) and the current marker inhibin B as single and combined markers of AGCTs. We conducted a longitudinal, partially prospective cohort study of 123 premenopausal and postmenopausal AGCT patients with a median follow-up time of 10.5 years (range 0.3-50.0 years). Serum AMH and inhibin B levels were measured from 560 pretreatment and follow-up serum samples by using immunoenzymometric assays. We found that serum AMH and inhibin B levels were significantly elevated in patients with primary or recurrent AGCTs. The levels of both markers positively correlated to tumor size (p < 0.05). AMH and inhibin B performed similarly in receiving operator characteristic analyses; area under the curve (AUC) values were 0.92 [95% confidence interval (CI) 0.88-0.95] for AMH, and 0.94 (95% CI 0.90-0.96) for inhibin B. AMH was highly sensitive (92%) and specific (81%) in detecting a macroscopic AGCT. However, in AUC comparison analyses, the combination of the markers was superior to inhibin B alone. In conclusion, serum AMH is a sensitive and specific marker of AGCT, and either AMH or inhibin B can be monitored during follow-up. However, combining AMH and inhibin B in AGCT patient follow-up improves the detection of recurrent disease.
AuthorsAnniina Färkkilä, Sanna Koskela, Saara Bryk, Henrik Alfthan, Ralf Bützow, Arto Leminen, Ulla Puistola, Juha S Tapanainen, Markku Heikinheimo, Mikko Anttonen, Leila Unkila-Kallio
JournalInternational journal of cancer (Int J Cancer) Vol. 137 Issue 7 Pg. 1661-71 (Oct 01 2015) ISSN: 1097-0215 [Electronic] United States
PMID25808251 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2015 UICC.
Chemical References
  • Biomarkers, Tumor
  • inhibin B
  • Inhibins
  • Anti-Mullerian Hormone
Topics
  • Adult
  • Aged
  • Anti-Mullerian Hormone (blood)
  • Biomarkers, Tumor (blood)
  • Cohort Studies
  • Female
  • Follow-Up Studies
  • Granulosa Cell Tumor (blood)
  • Humans
  • Inhibins (blood)
  • Longitudinal Studies
  • Middle Aged
  • Ovarian Neoplasms (blood)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: